NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses

por Kounnas, Maria Z., Durakoglugil, Murat S., Herz, Joachim, Comer, William T.
Publicado 2019

NGP 555, a γ-secretase modulator, lowers the amyloid biomarker, Aβ(42,) in cerebrospinal fluid while preventing Alzheimer's disease cognitive decline in rodents

por Kounnas, Maria Z., Lane-Donovan, Courtney, Nowakowski, Dan W., Herz, Joachim, Comer, William T.
Publicado 2016